The Institute of Mental Health in Belgrade, established in 1963, is the first social-psychiatric institution in Southeast Europe.

There are 120 (2017) beds in Institute of Mental Health.

During the past decade, Institute of Mental Health conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 10 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Mental Health" #1 sponsor was "Sunovion" with 6 trials, followed by "H. Lundbeck A/S" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "SK Life Science, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Mental Health" #1 collaborator was "Clinical Centre of Serbia" with 2 trials as a collaborator, "Institute of Mental Health, Serbia" with 2 trials as a collaborator, "Military Medical Academy, Belgrade, Serbia" with 2 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Mental Health" are "Schizophrenia" (7 trials), "Depressive Disorder, Major" (6 trials), "Bipolar Disorder" (2 trials), "Partial Epilepsy" (2 trials) and "Bipolar 1 Depression" (1 trials). Many other conditions were trialed in "Institute of Mental Health" in a lesser frequency.

Most popular intervention types in "Institute of Mental Health" are "Drug" (20 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Lurasidone" (3 trials), "Cariprazine" (2 trials), "YKP3089" (2 trials) and "Aticaprant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Mental Health" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Mental Health". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Institute of Mental Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Mental Health, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".